Dr Lalchandani Labs Ltd - 541299 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dr Lalchandani Labs Limited has informed the Exchange regarding Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2021. Dr Lalchandani Labs Ltd - 541299 - Compliances- Compliance Certificate For The Period Ended March 31, 2021
Compliances- Compliance Certificate under Regulation 7(3) for the period ended March 31, 2021. Dr Lalchandani Labs Ltd - 541299 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Swati PoddarDesignation :- Company Secretary and Compliance Officer Dr Lalchandani Labs Ltd - 541299 - Intimation For The Appointment Of Internal Auditor.
Dr Lalchandani Labs Limited wish to inform BSE that M/s Vikas Bagga & Co. has been appointed as an Internal Auditor of the Company in a meeting held on 13th March 2021. Dr Lalchandani Labs Ltd - 541299 - Announcement Regarding Approval For COVID-19 Vaccination Centre.
Dr Lalchandani Labs Limited are hereby glad to announce that we have associated with the government on the nationwide vaccination program, and for same got the approval from central and state government to be listed as COVID-19 Vaccination Centre. We have started with our operation and expect to optimize our services towards our client in a better way to fight against the COVID-19 pandemic. Dr Lalchandani Labs Ltd - 541299 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the Quarter ended December 31, 2020. Dr Lalchandani Labs Ltd - 541299 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SWATI PODDARDesignation :- Company Secretary and Compliance Officer Dr Lalchandani Labs Ltd - 541299 - Results - Submission Of Revised Un-Audited Financial Results For The Half-Year Ended September 30, 2020.
We hereby submitting the Revised Un-Audited Financial Results for the half year ended September 30, 2020. 1. Un-Audited Financial Results for the half year ended as on September 30, 2020. 2. Un-Audited Statement of Assets and Liabilities for the half year ended as on September 30, 2020. 3. Cash Flow Statement for the half year ended as on September 30, 2020. 4. Limited Review Report for the half year ended as on September 30, 2020. Dr Lalchandani Labs Ltd - 541299 - Unaudited Financial Results For The Half Year Ended September 30, 2020
We are hereby submitting the Unaudited Financial Results along with Limited Review Report for the half year ended on 30th September, 2020. 1. Un-audited Financial Results for the half year ended on 30th September, 2020. 2. Un-audited Statement of Assets and Liabilities for the half year ended on 30th September, 2020. 3. Cash Flow Statement for the half year ended on 30th September, 2020. 4. Limited Review Report for the half year ended 30th September, 2020.